<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04577248</url>
  </required_header>
  <id_info>
    <org_study_id>GE DHM-AN-EHK-2020/09</org_study_id>
    <nct_id>NCT04577248</nct_id>
  </id_info>
  <brief_title>The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry</brief_title>
  <acronym>OBSERV-MITRA</acronym>
  <official_title>The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, single-center observational registry including all consecutive patients treated&#xD;
      with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München,&#xD;
      Germany.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long-term mortality after transcatheter mitral or tricuspid valve therapy&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Long-term mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Long-term mortality</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Mitral Valve Regurgitation</condition>
  <condition>Mitral Valve Stenosis</condition>
  <condition>Tricuspid Valve Regurgitation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>edge-to-edge valve repair</intervention_name>
    <description>edge-to-edge valve repair</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All-comers patient population treated with transcatheter mitral or tricuspid valve therapy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age above 18 years and consentable&#xD;
&#xD;
          -  Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation,&#xD;
             Tricuspid Stenosis&#xD;
&#xD;
          -  Transcatheter mitral or tricuspid valve therapy considered best option by heart-team&#xD;
             decision&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's inability to fully cooperate with the protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Mayr, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology, Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Joner, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Cardiology, Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tobias Rheude, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Cardiology, Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Costanza Pellegrini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Cardiology, Deutsches Herzzentrum München</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick Mayr, MD</last_name>
    <phone>+498912180</phone>
    <email>mayrp@dhm.mhn.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joner Michael, Prof</last_name>
    <phone>+498912180</phone>
    <email>joner@dhm.mhn.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>D80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick Mayr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 1, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
    <mesh_term>Mitral Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

